News

The Mysterious Eugenics of Aesthetic Taste

By Michael Rossi, The Los Angeles Review of Books | 01.11.2026

This is the 10th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...

Arts & Culture

The mirage of AI deregulation

By Alondra Nelson, Science | 01.15.2026

One of the most interventionist approaches to technology governance in the United States in a generation has cloaked itself in the language of deregulation. In early December 2025, President Donald Trump took to Truth Social to announce a forthcoming “One...

Global Governance

More and “Better” Babies: The Dark Side of the Pronatalist Movement

By Daphne O. Martschenko and Julia E. H. Brown, Hastings Bioethics Forum | 01.14.2026

There is growing concern that falling fertility rates will lead to economic and demographic catastrophe. The social and political movement...

Genetic Selection

Bay Area Startups Want to Make Genetically Engineered Babies. What Could Go Wrong?

By Grace Won, KQED Forum [with CGS' Katie Hasson] | 12.02.2025

In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby...

Genetic Selection

India’s DNA COVID vaccine is a world first – more are coming

By Smriti Mallapaty, Nature | 09.02.2021

India has approved a new COVID-19 vaccine that uses circular strands of DNA to prime the immune system against the...

Other Countries

Kazuto Kato: the ethics of editing humanity

By Gary Humphreys, Bulletin of the World Health Organization | 09.01.2021

^{Photo from Kazuto Kato’s biography at

University of Oxford’s Faculty of Law}

Gary Humphreys talks to Kazuto Kato about the...

Human Genetic Modification

We Haven’t Really Cracked the Code of Life

By Jag Bhalla, Issues in Science and Technology | 09.01.2021

To say that scientists now understand life’s “code” is a stretch. So, from the very title of Walter Isaacson’s latest...

Society

CRISPR-Based Therapeutics Blaze an In Vivo Path to the Clinic

By Ashleen Knutsen, Genetic Engineering and Biotechnology News | 09.01.2021

Therapeutic applications of genome editing were envisioned at least as early as the mid-1990s, when the first sequence-specific genome editing...

Human Genetic Modification

What’s next for lab-grown human embryos?

By Kendall Powell, Nature | 08.31.2021

It was day 13 in a set of experiments in Ali Brivanlou’s laboratory and he had an agonizing task ahead...

Animal Biotechnologies

New gene therapies may soon treat dozens of rare diseases, but million-dollar price tags will put them out of reach for many

By Kevin Doxzen, The Conversation | 08.31.2021

Zolgensma – which treats spinal muscular atrophy, a rare genetic disease that damages nerve cells, leading to muscle decay...

Human Genetic Modification

Rogue Stem Cell Clinics, CIRM and the Feds

By David Jensen, The California Stem Cell Report | 08.31.2021

The California stem cell agency has posted a bit of a roundup on the state of regulatory affairs concerning what...

Stem Cells

13X Paralympic Medalist from Team USA, Tatyana McFadden

Strides made but stigmas remain: Japan hesitant in embracing Paralympics

By Gavin Blair, The Guardian | 08.30.2021

^{13X Paralympic Medalist from Team USA, Tatyana McFadden,}
^{by Samsung Newsroom is licensed under CC BY-NC-SA 2.0}

When the Tokyo ...

Public Opinion